Trial Details

COMPLETED
Basic Information
Clinical ID c3985
Identifier NCT01233960
Trial Title Evaluation of PROCHYMAL® for Treatment-refractory Moderate-to-severe Crohn's Disease
Trial URL Visit Original Page
Study Information
Study Results

NO
Conditions Crohn's Disease
Interventions DRUG: Prochymal®
Participant Information
Sponsor Mesoblast, Inc.
City San Francisco
Country/Region United States
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE3
Time Information
Start Date 2010-11-29
Primary Completion Date 2014-09-15
Completion Date 2014-09-15